HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LE135, a retinoid acid receptor antagonist, produces pain through direct activation of TRP channels.

AbstractBACKGROUND AND PURPOSE:
Retinoids, through their activation of retinoic acid receptors (RARs) and retinoid X receptors, regulate diverse cellular processes, and pharmacological intervention in their actions has been successful in the treatment of skin disorders and cancers. Despite the many beneficial effects, administration of retinoids causes irritating side effects with unknown mechanisms. Here, we demonstrate that LE135 [4-(7,8,9,10-tetrahydro-5,7,7,10,10-pentamethyl-5H-benzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)benzoic acid], a selective antagonist of RARĪ² , is a potent activator of the capsaicin (TRPV1) and wasabi (TRPA1) receptors, two critical pain-initiating cation channels.
EXPERIMENTAL APPROACH:
We performed to investigate the excitatory effects of LE135 on TRPV1 and TRPA1 channels expressed in HEK293T cells and in dorsal root ganglia neurons with calcium imaging and patch-clamp recordings. We also used site-directed mutagenesis of the channels to determine the structural basis of LE135-induced activation of TRPV1 and TRPA1 channels and behavioural testing to examine if pharmacological inhibition and genetic deletion of the channels affected LE135-evoked pain-related behaviours.
KEY RESULTS:
LE135 activated both the capsaicin receptor (TRPV1) and the allyl isothiocyanate receptor (TRPA1) heterologously expressed in HEK293T cells and endogenously expressed by sensory nociceptors. Mutations disrupting the capsaicin-binding site attenuated LE135 activation of TRPV1 channels and a single mutation (K170R) eliminated TRPA1 activity evoked by LE135. Intraplantar injection of LE135 evoked pain-related behaviours. Both TRPV1 and TRPA1 channels were involved in LE135-elicited pain-related responses, as shown by pharmacological and genetic ablation studies.
CONCLUSIONS AND IMPLICATIONS:
This blocker of retinoid acid signalling also exerted non-genomic effects through activating the pain-initiating TRPV1 and TRPA1 channels.
AuthorsShijin Yin, Jialie Luo, Aihua Qian, Weihua Yu, Hongzhen Hu
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 171 Issue 6 Pg. 1510-20 (Mar 2014) ISSN: 1476-5381 [Electronic] England
PMID24308840 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2013 The British Pharmacological Society.
Chemical References
  • Dibenzazepines
  • LE 135
  • Receptors, Retinoic Acid
  • Transient Receptor Potential Channels
Topics
  • Animals
  • Behavior, Animal
  • Dibenzazepines (pharmacology)
  • HEK293 Cells
  • Humans
  • Hyperalgesia
  • Mice
  • Mice, Inbred C57BL
  • Molecular Sequence Data
  • Pain (chemically induced)
  • Receptors, Retinoic Acid (antagonists & inhibitors)
  • Transient Receptor Potential Channels (agonists)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: